Plasmid Profiling and Occurrence of β-Lactamase Enzymes in Multidrug-Resistant Uropathogenic Escherichia coli in Kathmandu, Nepal

References

• Pokharel S, Raut S, Adhikari B. Tackling antimicrobial resistance in low-income and middle-income countries. BMJ Glob Health. 2019;4(6):e002104. doi:10.1136/bmjgh-2019-002104
   PubMed Web of Science ®Google Scholar
• Parajuli NP, Acharya SP, Mishra SK, Parajuli K, Rijal BP, Pokharel BM. High burden of antimicrobial resistance among Gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. Antimicrob Resist Infect Control. 2017;6(1):67. doi:10.1186/s13756-017-0222-z28638594
   PubMed Web of Science ®Google Scholar
• Gajdacs M. The concept of an Ideal antibiotics: implications for drug design. Molecules. 2019;24(5):892. doi:10.3390/molecules24050892
   PubMed Web of Science ®Google Scholar
• Raut S, Adhikari B. ESBL and their identification in peripheral laboratories of Nepal. Nepal Med Coll J. 2015;17(3–4):176–181.
   Google Scholar
• Guragin N, Pradhan A, Dhungel B, Banjara MR, Rijal KR, Ghimire P. Extended spectrum B-lactamase producing Gram negative bacterial isolates from urine of patients visiting Everest Hospital, Kathmandu, Nepal. TUJM. 2019;6(1):26–31.
   Google Scholar
• Kayastha K, Dhungel B, Karki S, et al. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in pediatric patients visiting International Friendship Children’s Hospital, Kathmandu, Nepal. Infect Dis. 2020;13:1–7.
   Google Scholar
• Woerther PL, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended-spectrum b-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev. 2013;26(4):744–758. doi:10.1128/CMR.00023-1324092853
   PubMed Web of Science ®Google Scholar
• Jacoby GA. AmpC β-lactamases. Clin Microbiol Rev. 2009;22(9):161–82.19136439
   PubMed Web of Science ®Google Scholar
• Deshmukh DG, Damle AS, Bajaj JK, Bhakre JB. The metallo β-lactamase producing clinical isolates from the patients of a tertiary care hospital. J Lab Physicians. 2011;3(2):93–97. doi:10.4103/0974-2727.8684122219562
   PubMedGoogle Scholar
• Bush K. Alarming beta-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol. 2010;13:558–564. doi:10.1016/j.mib.2010.09.00620920882
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L, Toleman MA, Walsh TR. Does broad spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? Antimicrob Agents Chemother. 2011;66(4):689–692. doi:10.1093/jac/dkq520
   Web of Science ®Google Scholar
• Pitout JD. Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol. 2012;3:9. doi:10.3389/fmicb.2012.0000922294983
   PubMed Web of Science ®Google Scholar
• Sharma M, Pathak S, Srivastava P. Prevalence and antibiogram of extended spectrum-ß-lactamase (ESBL) producing Gram-negative bacilli and further molecular characterization of ESBL producing E. coli and Klebsiella spp. J Clin & Diag Res. 2013;7(10):2173–2177.
   PubMedGoogle Scholar
• Saeed A, Khatoon H, Ansari FA. Multidrug resistant Gram-negative bacteria in clinical isolates from Karachi. Pak J Pharm Sci. 2009;22:44–48.19168419
   PubMed Web of Science ®Google Scholar
• Motayo BO, Ogiogwa IJ, Okerentugba PO, et al. Antimicrobial resistance profile of Extra-intestinal E. coli infections in a Southwestern Nigerian City. J Microbiol Res. 2012;2(5):141–144. doi:10.5923/j.microbiology.20120205.05
   Google Scholar
• Munita JM, Arias CA. Mechanism of antibiotic resistance. Microbial Spectra. 2016;4(2):10.
   Web of Science ®Google Scholar
• Adelberg EA, Pittard J. Chromosome transfer in bacterial conjugation. Bacteriol Rev. 1965;29(2):161–172. doi:10.1128/MMBR.29.2.161-172.196514310189
   PubMedGoogle Scholar
• Rozwandowicz M, Brouwer MSM, Fischer J, et al. Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J Antimicrobial Chemother. 2018;73(5):1121–1137. doi:10.1093/jac/dkx488
   PubMed Web of Science ®Google Scholar
• Tayfour MA, Eris FN, Alanazi AR. Comparison of antibiotic susceptibility tests, plasmids profiles and restriction enzyme analysis of plasmid DNA of methicillin susceptible and resistant Staphylococcus aureus strains isolated from intensive care units. Saudi Med J. 2005;26(1):57–63.15756354
   PubMed Web of Science ®Google Scholar
• Pradhan B, Pradhan SB. Prevalence of urinary tract infection and antibiotic susceptibility pattern to urinary pathogens in Kathmandu Medical College and Teaching Hospital, Duwakot. BJHS. 2017;2(1):134–137.
   Google Scholar
• Gajdacs M, Urban E. Resistance Trends and epidemiology of Citrobacter-Enterobacter- Serratia in urinary tract infections of inpatients and outpatients (RECESUTI): a 10-year survey. Medicina. 2019;55(6):285. doi:10.3390/medicina55060285
   Web of Science ®Google Scholar
• Gajdacs M, Abrok M, Lazar A, Burain K. Comparative epidemiology and resistance trends of common urinary pathogens in a tertiary care hospital: a 10-year surveillance study. Medicina. 2019;55(7):356. doi:10.3390/medicina55070356
   Web of Science ®Google Scholar
• Raut S, Gokhale S, Adhikari B. Prevalence of extended spectrum beta-lactamases among Escherichia coli and Klebsiella spp. Isolates in Manipal Teaching Hospital, Pokhara, Nepal J Microbiol and Infect Dis. 2015;5(2):69–75.
   Google Scholar
• Raut S, Adhikari B. Global leadership against antimicrobial resistance ought to include developing countries. Lancet Infect Dis. 2016;16(7):775. doi:10.1016/S1473-3099(16)30078-0
   Web of Science ®Google Scholar
• Sharma AR, Bhatta DR, Shrestha J, Banjara MR. Antimicrobial susceptibility pattern of Escherichia coli isolated from urinary tract infected patients attending Bir Hospital. Nep J Sci and Tech. 2013;14(1):177–184. doi:10.3126/njst.v14i1.8938
   Google Scholar
• Shrestha A, Manandhar S, Pokharel P, Panthi P, Chaudhry DK. Prevalence of extended spectrum beta-lactamase (ESBL) producing multidrug resistance Gram-negative isolates causing urinary tract infection. EC Microbiol. 2016;4(5):749–755.
   Google Scholar
• Sharma KR, Bhandari P, Adhikari N, Tripathi P, Khanal S, Tiwari BR. Extended spectrum ß-lactamase (ESBL) producing multi-drug resistant urinary pathogens in a children hospital from Nepal. Kathmandu Univ Med J (KUMS). 2018;16(62):151–155.
   Google Scholar
• Nepal K, Pant ND, Neupane B, et al. Extended spectrum beta-lactamase and metallo-beta-lactamase producing E. coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care- hospital in Kathmandu. Ann Clin Microbiol Antimicrob. 2017;19(16):62. doi:10.1186/s12941-017-0236-7
   Web of Science ®Google Scholar
• Rai S, Pant ND, Bhandari R, et al. AmpC and extended spectrum beta-lactamase production urinary isolates from a tertiary care hospital in Lalitpur, Nepal. BMC Res Notes. 2017;10(1):467. doi:10.1186/s13104-017-2784-528882177
   PubMedGoogle Scholar
• Hiroshi N. Multidrug resistance in Bacteria. Annu Rev Biochem. 2009;78:119–146. doi:10.1146/annurev.biochem.78.082907.14592319231985
   PubMed Web of Science ®Google Scholar
• Cheesbrough M. District Laboratory Practice in Tropical Countries, Part II. 2nd ed. New York: Cambridge university press; 2006:112–113.
   Google Scholar
• Isenberg HD. Clinical Microbiology Procedures Handbook. 2nd ed. Washington, DC: ASM Press; 2004.
   Google Scholar
• Clinical Laboratory Standard Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty Second Informational Supplement Document. Wayne, PA: CLSI; 2012:M100–S20.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pan drug resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Polsfuss S, Bloemberg GV, Giger J, Meyer V, Böttger EC, Hombach M. Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae. J Clinic Microbiol. 2011;49(8):2798–2803. doi:10.1128/JCM.00404-11
   PubMed Web of Science ®Google Scholar
• Tan TY, Yong-Ng LS, He J, Koh TH, Hsu LY. Evaluation of screening methods to detect plasmid mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Antimicrob Agents Chemother. 2009;53(1):146–149. doi:10.1128/AAC.00862-0818955528
   PubMed Web of Science ®Google Scholar
• Tsakris A, Poulou A, Pournaras S, et al. A simple phenotypic method for the differentiation of metallo-β-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. Antimicrob Agents Chemother. 2010;65(8):1664–1671. doi:10.1093/jac/dkq210
   Web of Science ®Google Scholar
• Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd NY: Cold Spring Harbor Laboratory Press, Cold Spring Harbor:1989.
   Google Scholar
• Daini OA, Adesemowo A. Antimicrobial susceptibility patterns and R-plasmids of clinical strains of Escherichia coli. Aust J Basic Appl Sci. 2008;2:397–400.
   Google Scholar
• Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol. 2010;7(12):653–660. doi:10.1038/nrurol.2010.19021139641
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA. Increasing antibiotic resistance among isolates of Escherichia coli recovered from inpatients and outpatients in a Saudi Arabian hospital. Infect Control Hosp Epidemiol. 2006;27:748–753. doi:10.1086/50533616807852
   PubMed Web of Science ®Google Scholar
• Salem MM, Muharram M, Alhosiny IM. Distribution of classes 1 and 2 integrons among multi drug resistant E. coli isolated from hospitalized patients with urinary tract infection in Cairo, Egypt. Aus J Basic and Appl Sci. 2010;4:398–407.
   Google Scholar
• Christopher AF, Hora S, Ali Z. Investigation of plasmid profile, antibiotic susceptibility pattern multiple antibiotic resistance index calculation of Escherichia coli isolates obtained from different human clinical specimens at tertiary care hospital in Bareilly-India. Ann Trop Med Public Health. 2013;6(3):285–289. doi:10.4103/1755-6783.120985
   Google Scholar
• Zhanel GG, Simor AE, Vercaigne L, Mandell L. Imipenem and meropenem: comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects. Can J Infect Dis. 1998;9(4):215–228. doi:10.1155/1998/83142522346545
   PubMedGoogle Scholar
• Piller CM, Torres MK, Brown NP, Shah D, Sahm DF. In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by Gram-negative bacteria, against recent clinical isolates from the United States. Antimicrob Agents Chemother. 2008;52(12):4388–4399. doi:10.1128/AAC.00381-0818779357
   PubMed Web of Science ®Google Scholar
• Padmini SB, Appalaraju B. Extended spectrum β-lactamases in urinary isolates of E. coli and Klebsiella pneumoniae, prevalence and susceptibility pattern in tertiary care hospital. Ind J Med Microbiol. 2004;223:172–174.
   Google Scholar
• Wachtler DA, Joshi MP, Rimal B. Antibiotic dispensing by drug retailers in Kathmandu, Nepal. Trop Med Int Health. 1999;4(11):782–788. doi:10.1046/j.1365-3156.1999.00476.x10588773
   PubMed Web of Science ®Google Scholar
• Nepal A, Hendrie D, Robinsons S, LA S. Survey of the pattern of antibiotic dispensing in private pharmacies in Nepal. BMJ Open. 2019;9(10):e032422. doi:10.1136/bmjopen-2019-032422
   Web of Science ®Google Scholar
• Khajuria A, Praharaj AK, Kumar M, Grover N. Emergence of Escherichia coli, co-producing NDM-1 and OXA-48 carbapenemases, in urinary isolates, at a tertiary care centre at Central India.. J Clin Diagn Res. 2014;8(6):DC01–4. doi:10.7860/JCDR/2014/7952.4413
   Google Scholar
• Hammer DA, Dongol S, Anderson TP, Wong JS, Werno AM, Murdoch DR. High prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Nepal. Int J Antimicrob Agents. 2007;30(5):471–472. doi:10.1016/j.ijantimicag.2007.07.00417851048
   PubMed Web of Science ®Google Scholar
• Baral P, Neupane S, Marasini BP, Ghimire KR, Lekhak B, Shrestha B. High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal. BMC Res Notes. 2012;5(1):38. doi:10.1186/1756-0500-5-3822260454
   PubMedGoogle Scholar
• Shrestha S, Mali NM, Tiwari KB, Adhikari N, Shrestha UT, Basnyat SR. Antibiogram and plasmid profiling of clinical multidrug resistant Escherichia coli. J Inst Med. 2014;35(2):21–26.
   Google Scholar
• Bora A, Ahmed GU, Hazarika NK. Antibiotic resistance pattern and prevalence of ESBL producing Escherichia coli isolates in urinary tract infection from a tertiary care hospital of Guwahati, Assam. IJBPAS. 2012;1(11):1659–1668.
   Google Scholar
• Manoharan A, Sugumar M, Kumar A, et al. Phenotypic and molecular characterization of AmpC β lactamases among Escherichia coli, Klebsiella spp and Enterobacter spp from five Indian medical centers. Indian J Med Res. 2012;135:359–364.22561623
   PubMed Web of Science ®Google Scholar
• Dhungana K, Awal BK, Dhungel B, Sharma S, Banjara MR, Rijal KR. Detection of Klebsiella pneumoniae carbapenemase (KPC) and metallo betalactamae (MBL) producing Gram negative bacteria isolated from different clinical samples in a Transplant Center, Kathmandu, Nepal. ASMI. 2019;2(12):60–69.
   Google Scholar
• Sasirekha B. Prevalence of ESBL, AmpC β- lactamases and MRSA among uropathogens and its antibiogram. EXCLI J. 2013;12:81–88.26417218
   PubMed Web of Science ®Google Scholar
• Yusuf AH, Arzai M, Haruna AA, Sharif GMI. Detection of multi drug resistant bacteria in major hospitals in Kano, North-West, Nigeria. Braz J Microbiol. 2014;45(3):791–798. doi:10.1590/S1517-8382201400030000525477909
   PubMed Web of Science ®Google Scholar
• Shayan S, Bokaeian M. Detection of ESBL- and AmpC-producing E. coli isolates from urinary tract infections. Adv Biomed Res. 2015;4(1):220. doi:10.4103/2277-9175.16664326605249
   PubMedGoogle Scholar
• Gajdacs M. Intravenous or oral antibiotic therapy: Sophie’s choice? Gen Int Med Clin Innov. 2019;4(2):1–2. doi:10.15761/GIMCI.1000176
   Google Scholar
• Zavascki AP, Barth AL, Gonçalves AL, et al. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother. 2006;58:387–392. doi:10.1093/jac/dkl23916751638
   PubMed Web of Science ®Google Scholar
• Rawat V, Singhai M, Verma PK. Detection of different β-lactamases and their co-existence by using various discs combination methods in clinical isolates of Enterobacteriaceae and Pseudomonas spp. J Lab Physicians. 2013;5:21–25. doi:10.4103/0974-2727.11591824014963
   PubMedGoogle Scholar
• Wadekar MD, Anuradha K, Venkatesha D. Phenotypic detection of ESBL and MBL in clinical isolates of Enterobacteriaceae. Int J Curr Res Acad Rev. 2013;1:89–95.
   Google Scholar
• Pandya NP, Prajapati SP, Mehta SJ, Kikani KM, Joshi PJ. Evaluation of various methods for detection of metallo-betalactamase (MBL) production in Gram-negative bacilli. Int J Biol Med Res. 2011;2(3):775–777.
   Google Scholar
• Moayednia R, Shokri D, Mobasherizadeh S, Baradaran A, Fatemi SM, Merrikhi A. Frequency assessment of β-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection. J Isfahan Uni Med Sci. 2014;19(1):S41–S45.
   Google Scholar
• Enwuru NV, Enwuru CA, Ogbonnia SO. Adepoju-Bello metallo-beta-lactamase production by Escherichia coli and Klebsiella species isolated from hospital and community subjects in Lagos, Nigeria Nature and Science. 2011;9(11):1–5.
   Google Scholar
• Oberoi L, Singh N, Sharma P, Aggarwal A. ESBL, MBL, AmpC β-lactamases producing superbugs – havoc in the intensive care units of Punjab, India. J Clin Diag Res. 2013;7(1):70–73.
   Google Scholar
• Urban C, Bradford PA, Tuckman M, et al. Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase β-lactamases associated with long-term care facilities. Clin Infect Dis. 2008;46(1):e127–30. doi:10.1086/58804818419424
   PubMed Web of Science ®Google Scholar
• Shrestha B, Shrestha S, Mishra SK, et al. Phenotypic characterization of multidrug-resistant Escherichia coli with special reference to extended-spectrum-beta-lactamases and metallo-beta-lactamases in a tertiary care center. J Nepal Med Assoc. 2015;53(198):89–95. doi:10.31729/jnma.2768
   Google Scholar
• Motayo BO, Akinduti PA, Adeyakinu FA, et al. Antibiogram and plasmid profiling of carbapenemase and extended spectrum beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in Abeokuta, South western, Nigeria. Afr Health Sci. 2013;13(4):1091–1097. doi:10.4314/ahs.v13i4.3324940337
   PubMedGoogle Scholar
• McPherson P, Gealt M. Isolation of indigenous wastewater bacterial strains capable of mobilizing plasmid pBR325. Appl Environ Microbiol. 1986;51(5):904–909. doi:10.1128/AEM.51.5.904-909.19863524455
   PubMed Web of Science ®Google Scholar
• Zulkifli Y, Alitheen NB, Raha AR, Yeap SK, Marlina SR, Nishibuchi M. Antibiotic resistance and plasmid profiling of Vibrio parahaemolyticus isolated from cockles in Padang, Indonesia. Inter Food Res J. 2009;16:53–58.
   Google Scholar